A closed-loop control system was constructed for automatic intravenous infusion of insulin to control blood sugar levels (BSL) in critically ill patients. We describe the development of the system. A total of nine subjects were recruited to clinically test the control system. In the patients who underwent closed-loop control of BSL, the controller managed to control only one patient's glycaemia without any manual intervention. The average BSL attained during closed-loop control approached the target range of 6-10 mmol/l, and had less deviation than when BSL had been maintained manually.
We conclude that closed-loop BSL control using a sliding scale algorithm is feasible. The main deficiency in the current system is unreliability of the subcutaneous glucose sensor when used in this setting. This deficiency mandates high vigilance during use of the system as it is being developed.
PfeifferE.F.Review. On the way to the automated (blood) glucose regulation in diabetes: the dark past, the gray present and the rosy future.Diabetologia1987; 30: 51–65.
2.
JaremkoJ., RorstadO.Advances toward the implantable artificial pancreas for treatment of diabetes.Diabetes Care1998; 21: 444–459.
3.
AlbisserA.M., LeibelB.S., EwartT.G., DavidovacZ., BotzC.K., ZinggW.Clinical control of diabetes by the artificial pancreas.Diabetes1974; 23: 397–404.
4.
ClemensA.H., ChangP.H., MyersR.W.The development of Biostator, a glucose-controlled insulin infusion systems (GCIIS).Horm Metab Res1977; 8(Suppl): 23–33.
5.
PfeifferE.F.The glucose sensor: the missing link in diabetes therapy.Horm Metab Res1990; 24(Suppl): 154–164.
6.
PickupJ.C.Clinical applications of infusion systems.J Med Eng Technol1984; 8: 101–107.
7.
SelamJ.L., CharlesM.A.Devices for insulin administration.Diabetes Care1990; 13: 955–976.
8.
HeinemannL., Ampudia-BlascoF.J.Glucose clamps with the Biostator: A critical reappraisal.Horm Metab Res1994; 26: 579–583.
9.
PickupJ., McCartneyL., RolinskiO., BirchD.In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring.MBJ1999; 139: 1–4.
10.
MarwickC.Development of noninvasive methods to monitor blood glucose levels in people with diabetes.JAMA1998; 280: 312–313.
11.
MeyerhoffC., BischófE., SternbergF., ZierH., PfeifferE.F.On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis.diabetologia1992; 35: 1087–1092.
12.
PoitoutV., Moatti-SiratD., ReachG.A glucose monitoring system for on-line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit.Diabetologia1993; 36: 658–663.
13.
HashiguchiY., SakakidaM., NishidaK., UemuraT., KajiwaraK., ShichiriM.Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with micro-dialysis sampling method.Diabetes Care1994; 17: 387–396.
14.
RebrinK., FischerU., WoedtkeT.V., AbelP., BrunsteinE.Automated feedback control of subcutaneous glucose concentration in diabetic dogs.Diabetologia1989; 32: 573–576.
15.
ShichiriM., KawamoriR., GoriyaY.Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas.Diabetologia1983; 24: 179–184.
16.
ShichiriM., KawamoriR., GoriyaY., YamasakiY., HakuiN., AbeH.Closed-loop glycaemic control with a wearable artificial endocrine pancreas—variations in daily insulin requirements to glycemic response.Diabetes1984; 33: 1200–1202.
17.
MastrototaroJ.J., JohnsonK.W., HoweyD.C.Preliminary clinical results from an electroenzymatic glucose sensor implanted in subcutaneous tissue.Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society1992; 14: 154–154.
18.
MorffR.J., JohnsonK.W., LipsonD., MastrototaroJ.J., AndrewC.C., PotvinA.R.Microfabrication of reproducible, economical, electroenzymatic glucose sensors.Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society1990; 12: 483–484.
19.
ParkerR.S., DoyleF.J.III PeppasN.A.The intravenous route to blood glucose control.IEEE Engineering in Medicine and Biology200120: 65–73.
20.
MiniMed Pty Ltd,MiniMed cgms™ continuous glucose monitoring system User Manual, March 2000.
21.
WelbornT.A.Diabetes in the coronary care unit. In: Thompson PL. Coronary Care Manual.Churchill Livingstone, Medical Division of Pearson Professional Limited,1997; 585–587.
22.
CheeF., FernandoT., van HeerdenP.V.Closed-loop glucose control in critically ill patients using Continuous Glucose Monitoring System (CGMS) in real-time.Trans Inf Technol Biomed (in press).
23.
ClarkeW.L., CoxD., Gonder-FrederickL.A., CarterW., PohlS.L.Evaluating clinical accuracy of systems for self-monitoring of blood glucose.Diabetes Care1987; 10: 622–628.
24.
AltmanD.G.Practical statistics for medical research, Chapman & Hall, London SE1 8HN, 1991.
25.
RebrinK., SteilG.M., Van AntwerpW.P., MastrototaroJ.J.Subcutaneous glucose predicts plasma glucose independent of insulin: Implications for continuous monitoring.Am J Physiol Endocrinol Metab1999; 277: E561–E571.
26.
Van Den BergheG., WoutersP., WeekersF.Intensive insulin therapy in critically ill patients.N Engl J Med2001; 345: 1359–1367.
